Perceptive Advisors as of June 30, 2013
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 87 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aegerion Pharmaceuticals | 22.8 | $226M | 3.6M | 63.34 | |
| Sarepta Therapeutics (SRPT) | 13.0 | $129M | 3.4M | 38.04 | |
| Neurocrine Biosciences (NBIX) | 7.3 | $72M | 5.4M | 13.38 | |
| Biogen Idec (BIIB) | 5.0 | $50M | 231k | 215.20 | |
| iShares NASDAQ Biotechnology Index (IBB) | 4.7 | $47M | 269k | 173.88 | |
| Acelrx Pharmaceuticals | 4.7 | $46M | 5.0M | 9.27 | |
| Gilead Sciences (GILD) | 4.3 | $43M | 837k | 51.26 | |
| Regeneron Pharmaceuticals (REGN) | 3.2 | $31M | 139k | 224.88 | |
| Tesaro | 3.0 | $30M | 921k | 32.74 | |
| EXACT Sciences Corporation (EXAS) | 2.3 | $23M | 1.6M | 13.91 | |
| Capital Senior Living Corporation | 2.1 | $21M | 891k | 23.90 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $21M | 257k | 80.06 | |
| Neptune Technologies Bioreso | 1.8 | $18M | 5.4M | 3.25 | |
| D Stemline Therapeutics | 1.4 | $14M | 592k | 23.84 | |
| Synta Pharmaceuticals | 1.4 | $13M | 2.7M | 4.99 | |
| Santarus | 1.3 | $13M | 625k | 21.05 | |
| ACADIA Pharmaceuticals (ACAD) | 1.3 | $13M | 727k | 18.15 | |
| Celgene Corporation | 1.1 | $11M | 96k | 116.98 | |
| Hca Holdings (HCA) | 1.1 | $11M | 309k | 36.06 | |
| Chelsea Therapeutics International | 1.1 | $11M | 4.7M | 2.30 | |
| Salix Pharmaceuticals | 1.0 | $9.8M | 148k | 66.15 | |
| Clovis Oncology | 0.9 | $9.4M | 141k | 66.98 | |
| NPS Pharmaceuticals | 0.9 | $8.5M | 562k | 15.11 | |
| Shire | 0.8 | $7.7M | 81k | 95.11 | |
| Aetna | 0.7 | $7.2M | 113k | 63.54 | |
| Optimer Pharmaceuticals | 0.7 | $7.2M | 497k | 14.47 | |
| Elan Corporation | 0.7 | $6.8M | 483k | 14.14 | |
| Astex Pharmaceuticals | 0.7 | $6.8M | 1.6M | 4.11 | |
| Spectranetics Corporation | 0.6 | $6.3M | 338k | 18.68 | |
| Dyax | 0.6 | $6.0M | 1.7M | 3.46 | |
| Athersys | 0.6 | $5.8M | 3.5M | 1.66 | |
| Curis | 0.5 | $4.4M | 1.4M | 3.19 | |
| Kamada Ord Ils1.00 (KMDA) | 0.4 | $4.4M | 395k | 11.16 | |
| Covidien | 0.4 | $4.2M | 68k | 62.84 | |
| Questcor Pharmaceuticals | 0.4 | $4.2M | 92k | 45.44 | |
| Sequenom | 0.4 | $4.1M | 985k | 4.21 | |
| Immunomedics | 0.4 | $4.0M | 739k | 5.44 | |
| Repros Therapeutics | 0.3 | $3.3M | 181k | 18.45 | |
| Anacor Pharmaceuticals In | 0.3 | $3.3M | 583k | 5.59 | |
| Arena Pharmaceuticals | 0.3 | $3.0M | 393k | 7.70 | |
| InterMune | 0.3 | $2.9M | 300k | 9.62 | |
| BioDelivery Sciences International | 0.2 | $1.9M | 478k | 4.06 | |
| Champions Oncology | 0.2 | $2.0M | 1.8M | 1.10 | |
| Infinity Pharmaceuticals (INFIQ) | 0.2 | $1.8M | 112k | 16.20 | |
| Neostem (NBS) | 0.2 | $1.8M | 3.3M | 0.55 | |
| Seattle Genetics | 0.2 | $1.6M | 50k | 31.46 | |
| Anthera Pharmaceuticals | 0.2 | $1.6M | 3.5M | 0.46 | |
| Cempra | 0.2 | $1.6M | 200k | 7.77 | |
| Mgc Diagnostics | 0.1 | $1.5M | 174k | 8.35 | |
| ViroPharma Incorporated | 0.1 | $1.4M | 48k | 28.65 | |
| Progenics Pharmaceuticals | 0.1 | $1.4M | 307k | 4.46 | |
| Vical Incorporated | 0.1 | $1.3M | 400k | 3.13 | |
| Tekmira Pharmaceuticals Corporation | 0.1 | $1.2M | 270k | 4.61 | |
| Amarin Corporation | 0.1 | $1.1M | 193k | 5.80 | |
| BioMed Realty Trust | 0.1 | $1.0M | 50k | 20.24 | |
| Cyclacel Pharmaceuticals | 0.1 | $1.0M | 350k | 2.95 | |
| Transgenomic | 0.1 | $883k | 2.2M | 0.40 | |
| Endocyte | 0.1 | $903k | 69k | 13.12 | |
| Uroplasty | 0.1 | $619k | 299k | 2.07 | |
| Medgenics | 0.1 | $570k | 150k | 3.80 | |
| Liposcience | 0.1 | $575k | 82k | 6.99 | |
| Epizyme | 0.1 | $506k | 18k | 28.11 | |
| Keryx Biopharmaceuticals | 0.0 | $374k | 50k | 7.48 | |
| Cutera | 0.0 | $421k | 48k | 8.79 | |
| INSTRS INC Stemcells | 0.0 | $382k | 232k | 1.65 | |
| Sunesis Pharmaceuticals | 0.0 | $301k | 58k | 5.19 | |
| Array BioPharma | 0.0 | $88k | 19k | 4.55 | |
| Neoprobe | 0.0 | $53k | 20k | 2.65 | |
| Endo Pharmaceuticals | 0.0 | $19k | 530.00 | 35.85 | |
| Omnicare | 0.0 | $20k | 425.00 | 47.06 | |
| WellCare Health Plans | 0.0 | $21k | 385.00 | 54.55 | |
| Health Management Associates | 0.0 | $20k | 1.3k | 15.81 | |
| CIGNA Corporation | 0.0 | $21k | 290.00 | 72.41 | |
| UnitedHealth (UNH) | 0.0 | $21k | 315.00 | 66.67 | |
| WellPoint | 0.0 | $21k | 255.00 | 82.35 | |
| VCA Antech | 0.0 | $20k | 780.00 | 25.64 | |
| Magellan Health Services | 0.0 | $20k | 365.00 | 54.79 | |
| Alere | 0.0 | $20k | 800.00 | 25.00 | |
| AmSurg | 0.0 | $20k | 565.00 | 35.40 | |
| Quest Diagnostics Incorporated (DGX) | 0.0 | $20k | 325.00 | 61.54 | |
| Hanger Orthopedic | 0.0 | $20k | 630.00 | 31.75 | |
| Hill-Rom Holdings | 0.0 | $20k | 590.00 | 33.90 | |
| Molina Healthcare (MOH) | 0.0 | $20k | 550.00 | 36.36 | |
| Healthsouth | 0.0 | $20k | 695.00 | 28.78 | |
| Mednax (MD) | 0.0 | $21k | 225.00 | 93.33 | |
| MedAssets | 0.0 | $20k | 1.2k | 17.39 | |
| Combimatrix Corporation *w exp 05/01/ | 0.0 | $1.0k | 5.0k | 0.20 |
